Cobalt Machine vs Linear Accelerator: Is an Older Machine Unsafe? — An Honest, Non-Alarmist Comparison

No — a cobalt-60 machine is not unsafe, and being treated on one is not being under-treated. Cobalt units are licensed, inspected and regulated by India's Atomic Energy Regulatory Board, exactly as linear accelerators are. Cobalt is an older technology, but older here means well-established, not unsafe.

What changed over the past three decades is not the safety of cobalt but the range of what a machine can do. A cobalt-60 unit holds a sealed radioactive source and delivers a steady gamma-ray beam. A linear accelerator makes X-rays electronically, produces no radiation at all when it is switched off, and can shape the beam far more tightly around an irregular target using a multi-leaf collimator. Both put dose where the plan says it should go. The linac simply has more ways to do it.

That difference matters enormously for some treatment plans and hardly at all for others. It is why a government hospital running a well-maintained cobalt unit can deliver entirely appropriate treatment for one patient while the person in the next queue genuinely needs a linac. The machine is not the whole story — the plan written for your tumour is.

Your radiotherapy is delivered at an NABH-accredited partner centre; CION Cancer Clinics coordinates your treatment plan, your oncology team and your care throughout, whichever machine your plan calls for.

Not automatically. For many prescriptions — palliative radiation for painful bone deposits, whole-brain treatment, straightforward two-field or four-field arrangements — a well-maintained cobalt unit delivers the prescribed dose as intended. Effectiveness becomes the issue only when the plan itself needs precision the machine cannot physically deliver.

The honest limits are these. A cobalt beam has a softer edge — a wider penumbra — so the dose falls away less sharply just outside the target. Its energy is fixed and lower than a linac's higher settings, which makes a deep-seated target in a large pelvis or abdomen harder to reach without putting more dose through the tissue in front of it. And a cobalt unit cannot deliver intensity-modulated (IMRT), volumetric-arc (VMAT) or image-guided (IGRT) plans, and it cannot produce electron beams for superficial disease.

Where those techniques are what your cancer needs — a head-and-neck plan that has to spare the salivary glands, a prostate plan that has to spare the rectum, a breast plan using deep inspiration breath hold to move the heart out of the field — a linear accelerator is not a luxury, it is the requirement. Where your prescription is a straightforward field arrangement, a cobalt unit meets it. NCCN and ASTRO guidance is written around the dose delivered and the target covered, not around a make of machine.

Ask your radiation oncologist one question: "Does the plan you have written for me need IMRT, IGRT, VMAT, electrons or breath-hold?" If the answer is no, most of the machine debate resolves itself.

Only if your plan needs one. Switching centres costs time, money and continuity of care, and delaying the start of radiation to chase a machine can do more harm than the machine difference would. Get a second opinion on the plan first; move only if the plan genuinely cannot be delivered where you are.

This is a decision with a sequence, and taking it in order protects you from both mistakes — accepting a plan the local machine cannot deliver, and uprooting your family for a machine you did not need.

• Get the written prescription, not a summary. The plan names the dose, the number of sittings and the technique. That document, not the hospital's reputation, is what decides whether the machine matters.
• Look for five words on it. IMRT, VMAT, IGRT, electrons, breath-hold. If any appear, a linear accelerator is required. If none appear, a cobalt unit can deliver what has been prescribed.
• Ask what the centre would do differently on a linac. A straight answer here is either "nothing material for your plan" or a specific structure they would be able to spare. Both answers are useful.
• Take a second opinion on the plan, not on the equipment. A radiation oncologist reviewing your scans and prescription can say whether the planned technique fits your disease. That is a different question from which machine is newer.
• Weigh the wait. A short wait to access the right technique is usually worth it. A long wait, when your current centre can deliver the prescribed plan, usually is not — and interruptions mid-course are their own problem.
• Count the whole cost of moving. Travel every weekday for several weeks, accommodation, lost earnings and a new set of investigations all belong in the comparison, not just the difference in package price.

If you want that second opinion without changing anything else, ask for it in writing and bring your simulation report and prescription. CION Cancer Clinics coordinates that review and, where a technique is needed, the plan is delivered at an NABH-accredited partner centre.

Usually yes on price, and usually no on eligibility. Treatment on a cobalt unit is generally the lower-cost option, because planning and delivery are simpler. Scheme cover, though, follows the approved package and the empanelment of the treating hospital — not the age of the machine standing in the bunker.

Aarogyasri, Ayushman Bharat PM-JAY, CGHS and most cashless insurance policies fund radiotherapy through defined packages at empanelled hospitals. Which machine an empanelled centre runs does not by itself decide whether you are covered; the diagnosis, the approved package and the centre's empanelment do. Where a specific technique such as IMRT is required, whether that technique sits inside your package is a question to settle in writing with the hospital's insurance desk before treatment starts, not after the first sitting.

All figures anyone quotes you are indicative only, as of August 2026, and shift with the centre, the technique, the number of sittings and the site being treated. Do not work from a verbal number. Ask for a written estimate that separates simulation, planning, delivery per sitting and review visits, so two centres can be compared on the same terms rather than on impressions.

If the cost of a linac-based technique is the obstacle, say so openly at your consultation. There is often more than one acceptable way to deliver a prescription, and that conversation is far more useful before planning begins than midway through a course.

• Been told your treatment will be placed inside the body rather than aimed from outside? HDR vs LDR Brachytherapy: Sessions, Stay and Safety compares the two internal-radiation approaches and what each means for your hospital stay.
• Facing breast radiation and worried about the heart sitting close to the field? Deep Inspiration Breath Hold: Protecting the Heart in Breast Radiation explains one technique that needs a linear accelerator to deliver.
• Heard the word "knife" and assumed an operation? Is Gamma Knife Actually Surgery? No Cuts, No Anaesthesia Explained clears up another machine-name confusion.
• Already had radiation once to the same area? Re-Irradiation: Can the Same Area Be Treated Twice? covers when a second course is considered and what limits it.
• For the wider picture — how radiation is planned, delivered and coordinated with NABH-accredited partner centres — see Radiation Therapy at CION Cancer Clinics.

Still unsure whether the machine at your centre suits your plan? Book a free consultation and a radiation oncologist will read your prescription with you, or call 1800 202 8726.